Emesent secures $17 million to accelerate autonomous intelligence platform

Emesent, an autonomous mapping and robotics company, today announced $17 million (USD) in total new funding to accelerate development of its Cortex AI autonomy platform, expand its Aura cloud software offering, and deepen its operations across the mining, defense, and architecture, engineering and construction (AEC) sectors. 

The raise comprises a $7 million venture debt facility from the National Reconstruction Fund Corporation (NRFC) — Australia’s sovereign investor in advanced manufacturing — and a $10 million equity round. The equity round was supported by a syndicate including Main Sequence, QIC Ventures, Orion Resource Partners, Hostplus, and NGS Super. 

Capital will be deployed to scale manufacturing at Emesent’s production facility in Wacol, Queensland, Australia, and to advance two strategic platform initiatives: Cortex AI, the company’s onboard autonomy intelligence that enables fully autonomous operations in GPS-denied and hazardous environments, and Aura, its cloud-based platform for 3D data processing, visualization, and analytics. Emesent currently employs 109 people across its Australian operations and plans to scale the business to meet growing demand from overseas markets. 

Emesent CEO Charles Miller said: “This investment accelerates everything we’re building at Emesent. Our clients operate in some of the most demanding environments on the planet, and they rely on our technology to make those environments understood.”

The NRFC investment marks the organization’s first venture debt deployment to a deep technology company, reflecting the Fund’s capacity to provide flexible, non-dilutive growth capital to Australian businesses that have demonstrated strong commercial traction. Emesent’s flagship Hovermap product is deployed across more than 200 mine sites globally and is considered mission-critical by some of the world’s largest mining operators, including Rio Tinto, BHP, and Glencore. 

NRFC CEO David Gall said: “Emesent’s pioneering physical AI technology was spun out of the CSIRO in 2018, and we are proud to be supporting the commercialization of Australian-developed intellectual property. Robotics and autonomous systems are emerging as critical segments of the Australian economy, and this investment will help anchor these capabilities in Australia — creating highly skilled jobs while strengthening our sovereign capability in sectors that underpin the nation’s future.” 

The investor syndicate reflects deepening institutional confidence in Australian deep technology companies operating at the intersection of hardware, AI, and autonomous systems. Main Sequence — an early backer of Emesent, having invested in its Seed and Series A rounds – returns alongside Queensland investor QIC Ventures, resources-focused Orion Resource Partners, and superannuation funds Hostplus and NGS Super. 

Mike Zimmerman, Partner at Main Sequence, said: “Since 2018, Emesent has been pioneering how clients map, understand and operate in some of the most complex, dangerous environments around the world, with millions of missions in hundreds of mines and worksites. We’re proud to continue supporting Emesent as they scale and make their world-leading autonomy and analytics platforms available to even more clients.” 

Emesent’s product portfolio includes the Hovermap STX LiDAR payload for drone, vehicle, and backpack deployments, the Emesent GX1 all-in-one SLAM, RTK, and 360° imagery scanner, Aura data processing software, and Cortex AI autonomous flight software — serving clients across mining, AEC, defense, and critical infrastructure in more than 40 countries.  

The funding announcement follows strong commercial momentum from Emesent GX1, which completed a global AEC Solutions roadshow spanning the Americas, Europe, and Asia. The company’s trajectory toward an autonomous intelligence platform model — anchored by Cortex AI and Aura — is designed to extend the value of its hardware deployments through continuous software intelligence and cloud-enabled services.